GlassScriptPhysician profile
Clifton A Baker
NPI 1053370098
$5,094.20
in general payments reported to CMS, 2019-2025
41 companies · $703 in 2025
The $703 reported for 2025 was more than what 88% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $295 · 2020: $391 · 2021: $891 · 2022: $694 · 2023: $1,033 · 2024: $1,088 · 2025: $703.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,823.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $765.60 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $654.96 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $622.34 | 2019-2025 | Jardiance, Mounjaro, Emgality |
| Abbvie INC. | $348.88 | 2021-2025 | Vraylar |
| Kowa Pharmaceuticals America, INC. | $268.07 | 2020-2022 | |
| Exact Sciences Corporation | $254.76 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $243.81 | 2020-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $178.84 | 2021-2022 | |
| Astellas Pharma US INC | $178.69 | 2019-2024 | Veozah |
| Amarin Pharma, INC. | $168.75 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $158.91 | 2020-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $144.38 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $131.04 | 2022-2023 | |
| Pfizer INC. | $91.49 | 2024-2025 | |
| Biohaven Pharmaceuticals, INC. | $86.31 | 2020-2021 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clifton Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.